Epb41l5 Mouse (-)-demecolcine decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Demecolcine results in decreased expression of EPB41L5 mRNA CTD PMID:23649840 Epb41l5 Mouse 17beta-estradiol decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Estradiol results in decreased expression of EPB41L5 mRNA CTD PMID:31614463 Epb41l5 Mouse 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 Epb41l5 Mouse 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 Epb41l5 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of EPB41L5 mRNA CTD PMID:21570461 Epb41l5 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB41L5 mRNA CTD PMID:32109520 Epb41l5 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPB41L5 mRNA CTD PMID:21215274 more ... Epb41l5 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB41L5 mRNA CTD PMID:19465110 Epb41l5 Mouse 2,4-dinitrotoluene affects expression ISO Epb41l5 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of EPB41L5 mRNA CTD PMID:21346803 Epb41l5 Mouse 2,6-dinitrotoluene affects expression ISO Epb41l5 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of EPB41L5 mRNA CTD PMID:21346803 Epb41l5 Mouse 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of EPB41L5 mRNA CTD PMID:18648102 Epb41l5 Mouse 4,4'-sulfonyldiphenol increases methylation ISO EPB41L5 (Homo sapiens) 6480464 bisphenol S results in increased methylation of EPB41L5 gene CTD PMID:31601247 Epb41l5 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of EPB41L5 mRNA CTD PMID:28973697 Epb41l5 Mouse 6-propyl-2-thiouracil affects expression ISO Epb41l5 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of EPB41L5 mRNA CTD PMID:24780913 Epb41l5 Mouse acrylamide increases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of EPB41L5 mRNA CTD PMID:28959563 Epb41l5 Mouse all-trans-retinoic acid increases expression ISO EPB41L5 (Homo sapiens) 6480464 Tretinoin results in increased expression of EPB41L5 mRNA CTD PMID:21934132 and PMID:23724009 Epb41l5 Mouse all-trans-retinoic acid decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of EPB41L5 mRNA CTD PMID:33167477 Epb41l5 Mouse amphetamine decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Amphetamine results in decreased expression of EPB41L5 mRNA CTD PMID:30779732 Epb41l5 Mouse antirheumatic drug increases expression ISO EPB41L5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of EPB41L5 mRNA CTD PMID:24449571 Epb41l5 Mouse arsane increases methylation ISO EPB41L5 (Homo sapiens) 6480464 Arsenic results in increased methylation of EPB41L5 promoter CTD PMID:21291286 Epb41l5 Mouse arsenic atom increases methylation ISO EPB41L5 (Homo sapiens) 6480464 Arsenic results in increased methylation of EPB41L5 promoter CTD PMID:21291286 Epb41l5 Mouse arsenite(3-) multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to EPB41L5 mRNA] CTD PMID:32406909 Epb41l5 Mouse arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of EPB41L5 mRNA CTD PMID:35676786 Epb41l5 Mouse belinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 belinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509 Epb41l5 Mouse benzo[a]pyrene decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of EPB41L5 mRNA CTD PMID:20106945 more ... Epb41l5 Mouse benzo[a]pyrene increases methylation ISO EPB41L5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of EPB41L5 5' UTR CTD PMID:27901495 Epb41l5 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of EPB41L5 mRNA CTD PMID:22228805 Epb41l5 Mouse benzo[a]pyrene decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Benzo(a)pyrene results in decreased expression of EPB41L5 mRNA CTD PMID:21839799 Epb41l5 Mouse benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EPB41L5 mRNA] CTD PMID:22228805 Epb41l5 Mouse benzo[a]pyrene diol epoxide I affects expression ISO EPB41L5 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Epb41l5 Mouse Benzo[ghi]perylene increases expression EXP 6480464 1 and 12-benzoperylene results in increased expression of EPB41L5 mRNA CTD PMID:26377693 Epb41l5 Mouse bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EPB41L5 mRNA CTD PMID:26063408 Epb41l5 Mouse bisphenol A decreases methylation ISO EPB41L5 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of EPB41L5 gene CTD PMID:31601247 Epb41l5 Mouse bisphenol A decreases expression ISO EPB41L5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of EPB41L5 mRNA CTD PMID:33670352 Epb41l5 Mouse bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of EPB41L5 promoter CTD PMID:27334623 Epb41l5 Mouse bisphenol A decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of EPB41L5 mRNA CTD PMID:25181051 and PMID:34947998 Epb41l5 Mouse butanal decreases expression ISO EPB41L5 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of EPB41L5 mRNA CTD PMID:26079696 Epb41l5 Mouse cadmium dichloride decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of EPB41L5 mRNA CTD PMID:38568856 Epb41l5 Mouse caffeine increases phosphorylation ISO EPB41L5 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of EPB41L5 protein CTD PMID:35688186 Epb41l5 Mouse carbon nanotube affects expression EXP 6480464 Nanotubes and Carbon affects the expression of EPB41L5 mRNA CTD PMID:25554681 Epb41l5 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon analog results in decreased expression of EPB41L5 mRNA CTD PMID:25554681 Epb41l5 Mouse chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of EPB41L5 mRNA CTD PMID:23125180 Epb41l5 Mouse cisplatin increases phosphorylation EXP 6480464 Cisplatin results in increased phosphorylation of EPB41L5 protein CTD PMID:22006019 Epb41l5 Mouse copper atom multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of EPB41L5 mRNA CTD PMID:20971185 Epb41l5 Mouse copper(0) multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of EPB41L5 mRNA CTD PMID:20971185 Epb41l5 Mouse copper(II) sulfate decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of EPB41L5 mRNA CTD PMID:19549813 Epb41l5 Mouse coumarin increases phosphorylation ISO EPB41L5 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of EPB41L5 protein CTD PMID:35688186 Epb41l5 Mouse coumestrol multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 Epb41l5 Mouse coumestrol decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Coumestrol results in decreased expression of EPB41L5 mRNA CTD PMID:19167446 Epb41l5 Mouse diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of EPB41L5 mRNA CTD PMID:35676786 Epb41l5 Mouse dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 Epb41l5 Mouse dicrotophos decreases expression ISO EPB41L5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of EPB41L5 mRNA CTD PMID:28302478 Epb41l5 Mouse dorsomorphin multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Epb41l5 Mouse Enterolactone multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA CTD PMID:19167446 Epb41l5 Mouse entinostat multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 Epb41l5 Mouse entinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 entinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509 Epb41l5 Mouse epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of EPB41L5 mRNA CTD PMID:35436446 Epb41l5 Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of EPB41L5 mRNA CTD PMID:30319688 Epb41l5 Mouse formaldehyde decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of EPB41L5 mRNA CTD PMID:23649840 Epb41l5 Mouse geldanamycin increases expression ISO EPB41L5 (Homo sapiens) 6480464 geldanamycin results in increased expression of EPB41L5 mRNA CTD PMID:26705709 Epb41l5 Mouse hydrogen peroxide affects expression ISO EPB41L5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of EPB41L5 mRNA CTD PMID:20044591 Epb41l5 Mouse leflunomide increases expression ISO Epb41l5 (Rattus norvegicus) 6480464 leflunomide results in increased expression of EPB41L5 mRNA CTD PMID:24136188 Epb41l5 Mouse mercury dibromide increases expression ISO EPB41L5 (Homo sapiens) 6480464 mercuric bromide results in increased expression of EPB41L5 mRNA CTD PMID:26272509 Epb41l5 Mouse mercury dibromide multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 Epb41l5 Mouse methapyrilene decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of EPB41L5 mRNA CTD PMID:30467583 Epb41l5 Mouse N(4)-hydroxycytidine decreases expression EXP 6480464 N(4)-hydroxycytidine results in decreased expression of EPB41L5 mRNA CTD PMID:37748715 Epb41l5 Mouse N,N-diethyl-m-toluamide multiple interactions ISO Epb41l5 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of EPB41L5 gene CTD PMID:33148267 Epb41l5 Mouse N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of EPB41L5 gene CTD PMID:15755804 Epb41l5 Mouse nickel atom decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Nickel results in decreased expression of EPB41L5 mRNA CTD PMID:25583101 Epb41l5 Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of EPB41L5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of EPB41L5 mRNA CTD PMID:34911549 Epb41l5 Mouse panobinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 panobinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509 Epb41l5 Mouse panobinostat multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 Epb41l5 Mouse paracetamol increases expression ISO EPB41L5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of EPB41L5 mRNA CTD PMID:21420995 and PMID:22230336 Epb41l5 Mouse paraquat decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Paraquat results in decreased expression of EPB41L5 mRNA CTD PMID:32680482 Epb41l5 Mouse PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 Epb41l5 Mouse permethrin multiple interactions ISO Epb41l5 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of EPB41L5 gene CTD PMID:33148267 Epb41l5 Mouse phenylmercury acetate affects expression ISO EPB41L5 (Homo sapiens) 6480464 Phenylmercuric Acetate affects the expression of EPB41L5 mRNA CTD PMID:26272509 Epb41l5 Mouse phenylmercury acetate multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Epb41l5 Mouse pirinixic acid multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EPB41L5 mRNA CTD PMID:19710929 Epb41l5 Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of EPB41L5 mRNA CTD PMID:17426115 and PMID:20813756 Epb41l5 Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of EPB41L5 mRNA CTD PMID:18445702 Epb41l5 Mouse poly(I:C) multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [TL8-506 co-treated with Poly I-C] results in increased expression of EPB41L5 mRNA CTD PMID:35688559 Epb41l5 Mouse potassium chromate increases expression ISO EPB41L5 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of EPB41L5 mRNA CTD PMID:22714537 Epb41l5 Mouse progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of EPB41L5 mRNA CTD PMID:22238285 Epb41l5 Mouse quercetin decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Quercetin results in decreased expression of EPB41L5 mRNA CTD PMID:21632981 Epb41l5 Mouse resveratrol multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of EPB41L5 mRNA CTD PMID:19167446 Epb41l5 Mouse SB 431542 increases expression ISO EPB41L5 (Homo sapiens) 6480464 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of EPB41L5 protein CTD PMID:25670856 Epb41l5 Mouse SB 431542 multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Epb41l5 Mouse silicon dioxide decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of EPB41L5 mRNA CTD PMID:25895662 Epb41l5 Mouse silver atom decreases expression EXP 6480464 Silver results in decreased expression of EPB41L5 mRNA CTD PMID:27131904 Epb41l5 Mouse silver(0) decreases expression EXP 6480464 Silver results in decreased expression of EPB41L5 mRNA CTD PMID:27131904 Epb41l5 Mouse sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of EPB41L5 mRNA CTD PMID:30953684 Epb41l5 Mouse sodium arsenite decreases expression ISO EPB41L5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of EPB41L5 mRNA CTD PMID:29301061 and PMID:34032870 Epb41l5 Mouse sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of EPB41L5 mRNA CTD PMID:37682722 Epb41l5 Mouse sodium arsenite increases expression ISO EPB41L5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of EPB41L5 mRNA CTD PMID:38568856 Epb41l5 Mouse sunitinib increases expression ISO EPB41L5 (Homo sapiens) 6480464 Sunitinib results in increased expression of EPB41L5 mRNA CTD PMID:31533062 Epb41l5 Mouse temozolomide increases expression ISO EPB41L5 (Homo sapiens) 6480464 Temozolomide results in increased expression of EPB41L5 mRNA CTD PMID:31758290 Epb41l5 Mouse tetrachloromethane decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of EPB41L5 mRNA CTD PMID:31150632 Epb41l5 Mouse thimerosal decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Thimerosal results in decreased expression of EPB41L5 mRNA CTD PMID:27188386 Epb41l5 Mouse thioacetamide decreases expression ISO Epb41l5 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of EPB41L5 mRNA CTD PMID:34492290 Epb41l5 Mouse thiram increases expression ISO EPB41L5 (Homo sapiens) 6480464 Thiram results in increased expression of EPB41L5 mRNA CTD PMID:38568856 Epb41l5 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of EPB41L5 gene and titanium dioxide results in decreased methylation of EPB41L5 promoter CTD PMID:35295148 Epb41l5 Mouse trichostatin A decreases expression ISO EPB41L5 (Homo sapiens) 6480464 trichostatin A results in decreased expression of EPB41L5 mRNA CTD PMID:24935251 Epb41l5 Mouse trichostatin A multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Epb41l5 Mouse trichostatin A affects expression ISO EPB41L5 (Homo sapiens) 6480464 trichostatin A affects the expression of EPB41L5 mRNA CTD PMID:26272509 and PMID:28542535 Epb41l5 Mouse trichostatin A increases expression ISO EPB41L5 (Homo sapiens) 6480464 trichostatin A results in increased expression of EPB41L5 mRNA CTD PMID:24935251 Epb41l5 Mouse urethane increases expression ISO EPB41L5 (Homo sapiens) 6480464 Urethane results in increased expression of EPB41L5 mRNA CTD PMID:28818685 Epb41l5 Mouse valdecoxib increases expression ISO Epb41l5 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of EPB41L5 mRNA CTD PMID:24136188 Epb41l5 Mouse valproic acid decreases methylation ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of EPB41L5 gene CTD PMID:29154799 Epb41l5 Mouse valproic acid decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of EPB41L5 mRNA CTD PMID:23179753 and PMID:24935251 Epb41l5 Mouse valproic acid increases expression ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of EPB41L5 mRNA CTD PMID:24383497 more ... Epb41l5 Mouse valproic acid affects expression ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid affects the expression of EPB41L5 mRNA CTD PMID:25979313 and PMID:26272509 Epb41l5 Mouse valproic acid multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Epb41l5 Mouse vorinostat multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 Epb41l5 Mouse vorinostat decreases expression ISO EPB41L5 (Homo sapiens) 6480464 vorinostat results in decreased expression of EPB41L5 mRNA CTD PMID:27188386 Epb41l5 Mouse vorinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 vorinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509